Humana Inc vs TeraWulf Inc — how do they compare? Humana Inc trades at $437.41 (market cap $47.61B), while TeraWulf Inc trades at $13.91 (market cap $7.19B). The key difference: Humana Inc is far larger — about 6.6× TeraWulf Inc's market cap, and Humana Inc pays a 0.89% dividend while TeraWulf Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and TeraWulf Inc for 17 Days on average.
| HUM | WULF | |
|---|---|---|
Market Cap | $47.61B | $7.19B |
Volume | 1,827,332 | 27,440,950 |
Sector | Health | Financials |
52-Week High | $409.85 | $28.98 |
52-Week Low | $163.67 | $10.99 |
Typical Hold Time | 53 Days | 17 Days |
Enterprise Value | $54.97B | $9.80B |
Dividend Yield | 0.89% | — |
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 4.24% today, but maintains a bullish technical outlook with strong institutional support. The stock shows mixed fundamentals with revenue growth to $129.66B in 2025 but declining profit margins at 0.88%. Recent analyst upgrades, including Barclays' $515 target on September 25, 2026, highlight optimism despite ongoing Medicare Advantage plan adjustments affecting member transitions.
Investment outlook remains cautiously optimistic with a consensus price target of $432.63 offering 12% upside. Risks include margin compression, regulatory scrutiny from Medicare billing practices, and competitive pressures in managed care. The company's strong cash position of $20.44B and consistent dividend payments provide stability amid enrollment volatility.
WULF trades at $14.40, down 3.81% on the day, amid a volatile period for AI infrastructure stocks. The company shows strong analyst support with 14 buy ratings and a consensus price target of $34.92, but fundamentals reveal challenges: revenue of $168.46M in 2025 was overshadowed by a net loss of -$661.42M, resulting in negative profit margins. Recent news highlights the company's pivot to AI data center hosting, with UBS initiating bullish coverage citing constrained compute supply (UBS, September 23, 2026).
The outlook is bifurcated: analyst optimism contrasts with weak profitability and bearish technical signals. Investment opportunity lies in the AI hosting transition, but risks include persistent losses, high debt-to-asset ratio of 78.84%, and sector volatility. The stock's current price near key support at $14 suggests cautious sentiment despite long-term growth potential in AI infrastructure.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →TeraWulf develops, owns, and operates fully integrated digital infrastructure powered by predominantly zero-carbon energy. It utilizes a hybrid business model that combines industrial-scale Bitcoin mining with high-performance computing (HPC) and AI hosting, leveraging sustainable power sources like nuclear and hydroelectric to deliver low-cost, energy-efficient data center solutions.
Read more on WULF →